TAK — Takeda Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $66.14bn
- $92.15bn
- ¥5tn
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)
Takeda to seek Japan approval for gastric cancer drug next year
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: FDA Directs Takeda To Add Boxed Warning To Adzynma Drug Label
Roche proposes former Takeda CEO for board seat
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Dr. Reddy's rises on India distribution deal for Takeda's dengue vaccine
Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine (updated)
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
Factbox: Pharma sector doubles down on AI to slash costs, timelines